Vision & Leadership
Our Team
Board of Directors
Advisory Board
Investors & Partners
Science & Pipeline
Mechanism
Pipeline
Publications
Clinical Trial
Clinical Trial
SCI Advisory Committee
Commitment to SCI
Expanded Access Policy
News
Contact
Vision & Leadership
Our Team
Board of Directors
Advisory Board
Investors & Partners
Science & Pipeline
Mechanism
Pipeline
Publications
Clinical Trial
Clinical Trial
SCI Advisory Committee
Commitment to SCI
Expanded Access Policy
News
Contact
Our Pipeline
Our lead program AXER-204 is in Phase 1/2 clinical trials and has Fast Track designation from FDA